Brown W J
Hutzel Hospital, Detroit, Michigan.
Antimicrob Agents Chemother. 1988 Mar;32(3):385-90. doi: 10.1128/AAC.32.3.385.
One hundred nine recent clinical isolates of anaerobic gram-negative bacteria were tested in triplicate by the National Committee for Clinical Laboratory Standards agar dilution procedure for their susceptibility to 32 antimicrobial agents. All isolates were inhibited by imipenem, but there were significant numbers of strains resistant to other beta-lactam drugs, and therefore the in vitro response to these antimicrobial agents cannot be predicted. This was particularly true for the bile-resistant or Bacteroides fragilis group. beta-Lactamase production was detected in 82% of the bacteroides with the nitrocefin test. Clavulanic acid combined with amoxicillin and ticarcillin and sulbactam combined with ampicillin resulted in synergistic activity against all beta-lactamase-positive organisms. Ceftizoxime was the most active of the cephalosporins. Two percent of the isolates were resistant to chloramphenicol and metronidazole. Clindamycin resistance was detected in 38% of the B. fragilis group, which is a marked increase from the 4% detected 10 years ago at this institution.
采用美国国家临床实验室标准委员会琼脂稀释法,对109株近期分离的厌氧革兰阴性菌进行三次重复试验,检测其对32种抗菌药物的敏感性。所有菌株均对亚胺培南敏感,但有相当数量的菌株对其他β-内酰胺类药物耐药,因此无法预测这些抗菌药物的体外反应。对于耐胆汁菌或脆弱拟杆菌群尤其如此。用硝基头孢菌素试验检测发现,82%的拟杆菌产生β-内酰胺酶。克拉维酸与阿莫西林联用、舒巴坦与氨苄西林联用,对所有β-内酰胺酶阳性菌均产生协同活性。头孢唑肟是头孢菌素类中活性最强的。2%的分离株对氯霉素和甲硝唑耐药。在脆弱拟杆菌群中,38%检测到克林霉素耐药,这比该机构10年前检测到的4%有显著增加。